Another Look at the Legal and Ethical Consequences of Pharmacological Memory Dampening: The Case of Sexual Assault
Jennifer A. Chandler
University of Ottawa - Common Law Section
University of Ottawa, Faculty of Law
T. Martin Rubio
Institut de recherches cliniques de Montréal
January 1, 2014
Journal of Law, Medicine and Ethics, Vol. 41, No. 4, 2013
Ottawa Faculty of Law Working Paper No. 2014-02
Research on the use of propranolol as a pharmacological memory dampening treatment for post-traumatic stress disorder is continuing and justifies another look at the legal and ethical issues raised in the past. We summarize the general ethical and legal issues raised in the literature so far, and we select two for in-depth reconsideration. We address the concern that a traumatized witness may be less effective in a prosecution emerging from the traumatic event after memory dampening treatment. We analyze this issue in relation to sexual assault, where the suggestion that corroborating evidence may remedy any memory defects is less likely to be helpful. We also consider the clinical ethical question about a physician’s obligation to discuss potential legal consequences of memory dampening treatment. We conclude that that this latter question reflects a general problem related to novel medical treatments where the broader socio-legal consequences may be poorly understood, and suggest that issues of this sort could usefully be addressed through the promulgation of practice guidelines.
Number of Pages in PDF File: 39
Keywords: neuroethics; neuroscience and law; memory dampening; witness; post-traumatic stress disorder; sexual assault
Date posted: February 9, 2014 ; Last revised: March 19, 2014
© 2015 Social Science Electronic Publishing, Inc. All Rights Reserved.
This page was processed by apollo2 in 1.234 seconds